NCT07307716

Brief Summary

This randomized crossover study will assess how three aligner-cleaning methods affect early supragingival oral microbial ecology and periodontal health in adults using clear aligners. Each participant will complete three (1-month) periods in a randomized sequence with (1-week) washouts between periods:

  1. 1.Mechanical toothbrushing with fluoride toothpaste (control),
  2. 2.Chlorhexidine (CHX) mouthwash, and
  3. 3.an oxygen-based cleanser (BlueM).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Feb 2026Oct 2026

First Submitted

Initial submission to the registry

December 15, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 29, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

January 8, 2026

Status Verified

January 1, 2026

Enrollment Period

8 months

First QC Date

December 15, 2025

Last Update Submit

January 6, 2026

Conditions

Keywords

Clear alignersChlorhexidineBlueMOxygen-based cleanserMechanical toothbrushingSupragingival plaqueAligner biofilmFusobacterium nucleatumPrevotella intermediaMMP-8Plaque indexGingival indexBleeding on probingRandomized crossover

Outcome Measures

Primary Outcomes (2)

  • Fusobacterium nucleatum CFU in supragingival plaque at the gingival margin (index teeth)

    Anaerobic culture enumeration (CFU) of Fusobacterium nucleatum from supragingival plaque collected along the gingival margin of upper/lower first molars and central incisors using the standardized swab/microbrush protocol. Species confirmation per SOP. Culture processing blinded under coded labels (P1-P3) by FA. Metric: CFU per specimen (report also as log10 CFU if analyzed).

    Baseline and end of each 1-month period (end of Period 1, Period 2, Period 3); 1-week washouts between periods.

  • Fusobacterium nucleatum CFU on retrieved aligner inner-surface biofilm

    Anaerobic culture enumeration (CFU) of Fusobacterium nucleatum from a standardized inner-surface swab of the used aligner (zones corresponding to gingival margins of index teeth). Species confirmation per laboratory SOP. Culture processing blinded under coded labels (P1-P3) by a single trained operator (FA). Metric: CFU per specimen (report also as log10 CFU if analyzed).

    Baseline and end of each 1-month period (end of Period 1, Period 2, Period 3); 1-week washouts between periods.

Secondary Outcomes (6)

  • Prevotella intermedia CFU on retrieved aligner inner-surface biofilm

    Baseline and end of each 1-month period (end of Period 1, Period 2, Period 3); 1-week washouts between periods.

  • Prevotella intermedia CFU in supragingival plaque at the gingival margin (index teeth)

    Baseline and end of each 1-month period (end of Period 1, Period 2, Period 3); 1-week washouts between periods.

  • MMP-8 concentration/activity in matrix-paired plaque and aligner extracts

    Baseline and end of each 1-month period (end of Period 1, Period 2, Period 3); 1-week washouts between periods.

  • Plaque Index (PI) at index teeth

    Baseline and end of each 1-month period (end of Period 1, Period 2, Period 3).

  • Gingival Index (GI) at index teeth

    Baseline and end of each 1-month period (end of Period 1, Period 2, Period 3).

  • +1 more secondary outcomes

Study Arms (3)

Sequence ABC: Brushing then CHX Mouthwash then BlueM

EXPERIMENTAL

Participant completes three 1-month periods in order (A to B to C), each separated by a 1-week washout. A = Mechanical toothbrushing with fluoride toothpaste (control); B = Chlorhexidine (CHX) mouthwash; C = Oxygen-based cleanser (BlueM). Trays are changed every 10 days; aligners are worn 22 h/day; water-only while aligners are in.

Behavioral: Mechanical toothbrushing (fluoride toothpaste)Drug: Chlorhexidine mouthwash (0.2%)Other: Oxygen-based cleanser

Sequence BCA: CHX Mouthwash then BlueM then Brushing

EXPERIMENTAL

Participant completes three 1-month periods in order (B to C to A), each separated by a 1-week washout. A = Mechanical toothbrushing with fluoride toothpaste (control); B = CHX mouthwash; C = Oxygen-based cleanser (BlueM). Trays are changed every 10 days; aligners are worn 22 h/day; water-only while aligners are in.

Behavioral: Mechanical toothbrushing (fluoride toothpaste)Drug: Chlorhexidine mouthwash (0.2%)Other: Oxygen-based cleanser

Sequence CAB: BlueM then Brushing then CHX Mouthwash

EXPERIMENTAL

Participant completes three 1-month periods in order (C to A to B), each separated by a 1-week washout. A = Mechanical toothbrushing with fluoride toothpaste (control); B = CHX mouthwash; C = Oxygen-based cleanser (BlueM). Trays are changed every 10 days; aligners are worn 22 h/day; water-only while aligners are in.

Behavioral: Mechanical toothbrushing (fluoride toothpaste)Drug: Chlorhexidine mouthwash (0.2%)Other: Oxygen-based cleanser

Interventions

Control oral-hygiene period using mechanical toothbrushing with a fluoride-containing toothpaste, per standardized study instructions, for the assigned 1-month period. No chlorhexidine or oxygen-based cleanser is used during this period; aligners are removed for oral-hygiene procedures per protocol.

Also known as: Colgate Total
Sequence ABC: Brushing then CHX Mouthwash then BlueMSequence BCA: CHX Mouthwash then BlueM then BrushingSequence CAB: BlueM then Brushing then CHX Mouthwash

Chlorhexidine mouthwash used per standardized study instructions for the assigned 1-month period. No oxygen-based cleanser is used during this period; aligners are removed for mouthrinse use and oral-hygiene procedures per protocol. A 1-week washout without cleaning products separates periods.

Also known as: CHX
Sequence ABC: Brushing then CHX Mouthwash then BlueMSequence BCA: CHX Mouthwash then BlueM then BrushingSequence CAB: BlueM then Brushing then CHX Mouthwash

Oxygen-based cleanser (BlueM) used per standardized study instructions for the assigned 1-month period. No chlorhexidine is used during this period; aligners are removed for product use and oral-hygiene procedures per protocol. A 1-week washout without cleaning products separates periods.

Also known as: BlueM
Sequence ABC: Brushing then CHX Mouthwash then BlueMSequence BCA: CHX Mouthwash then BlueM then BrushingSequence CAB: BlueM then Brushing then CHX Mouthwash

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (≥18 years).
  • Undergoing or scheduled for treatment with clear aligners (CA).
  • Presence of upper and lower first molars and central incisors.
  • Periodontal health at baseline (no sites with PD ≥ 4 mm; no clinical attachment loss at index teeth; BI/PI within normal limits).
  • No periodontal therapy within the previous 6 months.
  • Able and willing to comply with study instructions and follow-up visits; signed informed consent.
  • Sufficient remaining CA treatment (clinician-estimated): ≥ 14 weeks to safely cover three 1 month protocol periods plus washouts.
  • Minimum planned aligners remaining: ≥ 11 aligners (assuming 10 days/aligner) or equivalent continuous CA duration per treating orthodontist.

You may not qualify if:

  • Patients requiring orthognathic surgery
  • Uncontrolled systemic diseases (e.g., uncontrolled diabetes mellitus, autoimmune disease).
  • Pregnancy or lactation.
  • Use of systemic antibiotics and/or anti-inflammatory drugs within the last 3 months.
  • Periodontal therapy within the last 6 months.
  • Current tobacco use (smoking/smokeless) or vaping.
  • Limited/express CA plans (e.g., ≤ 11 aligners or expected completion \< 14 weeks).
  • Anticipated early completion of CA or major treatment changes (e.g., switch to fixed appliances) within the next \~4 months.
  • \- Extensive caries, defective restorations, or prostheses affecting index teeth/sites.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riyadh Elm University - Orthodontic Clinics

Riyadh, Riyadh Region, Saudi Arabia

Location

Related Publications (3)

  • Heller D, Helmerhorst EJ, Gower AC, Siqueira WL, Paster BJ, Oppenheim FG. Microbial Diversity in the Early In Vivo-Formed Dental Biofilm. Appl Environ Microbiol. 2016 Jan 8;82(6):1881-8. doi: 10.1128/AEM.03984-15.

    PMID: 26746720BACKGROUND
  • Zhao R, Huang R, Long H, Li Y, Gao M, Lai W. The dynamics of the oral microbiome and oral health among patients receiving clear aligner orthodontic treatment. Oral Dis. 2020 Mar;26(2):473-483. doi: 10.1111/odi.13175. Epub 2020 Jan 8.

    PMID: 31418980BACKGROUND
  • Miguel YD, Alcântara PR, Toyofuku ACMM, Shimizu RH. Periodontal monitoring in orthodontic treatment with orthodontic aligners: proof of concept. Rev Odontol UNESP. 2024;53:e20240016. doi:10.1590/1807-2577.01624

    BACKGROUND

MeSH Terms

Conditions

GingivitisDental Plaque

Interventions

hydrated silica gel-based toothpaste

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesDental DepositsTooth Diseases

Study Officials

  • Dr. Faisal A Althobaiti, BDS

    Riyadh Elm University

    PRINCIPAL INVESTIGATOR
  • Dr. Nancy M Ajwa, MSc

    Riyadh Elm University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Culture enumeration from plaque and retrieved aligners will be processed under coded labels (P1-P3) by a single trained operator (FA) who is masked to protocol assignment. Microscopy and clinical assessments will be conducted unblinded after decoding.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Three 1-month periods in randomized sequence (ABC/BCA/CAB) with 1-week washouts between the groups. A = mechanical toothbrushing (fluoride toothpaste), B = chlorhexidine mouthwash, C = oxygen-based cleanser (BlueM). Algners changed every 10 days; water-only while aligners are in
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 15, 2025

First Posted

December 29, 2025

Study Start

February 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

January 8, 2026

Record last verified: 2026-01

Locations